Prosecution Insights
Last updated: October 14, 2026

Regents of the University of Minnesota

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

89 pending office actions • 59 art units • 89 examiners • 0 of 89 (0%) have an AI response strategy ready • 75 patents granted in the last 365 days

Analysis

Regents of the University of Minnesota is managing 90 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 88 distinct examiners and 47 distinct art units. This indicates a large and diverse portfolio with many different individuals and specialized groups involved. The 47 distinct art units show that the university's research covers a vast array of technical classifications within the biotech and pharmaceutical sectors.

PATEL, RONAK C is the busiest examiner, with 2 pending office actions. The other pending actions are spread among the other distinct examiners. With 88 distinct examiners involved, the university faces a high degree of variability in how its applications are reviewed. The 47 distinct art units for 90 actions indicate that while some specialized groups handle multiple applications, the individual examiners within those groups are mostly unique. Practitioners must manage separate prosecution tracks, as the high number of examiners limits the ability to reuse successful negotiation tactics across the portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

89
Total Pending OAs
63
Non-Final OAs
21
Final Rejections
5
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 27 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

12
Overdue
1
Due this week
8
Due this month
5
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 27 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (12)Due ≤ 7 days (1)Due ≤ 30 days (8)Due ≤ 60 days (5)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

54
Hard (61%)
30
Medium (34%)
5
Easy (6%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (2%)
§101 + other10 (11%)
§103 only23 (26%)
§112 only3 (3%)
Double-patenting only2 (2%)
Double-patenting + other7 (8%)
Multi-statute (no §101)42 (47%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

52
Life Sciences
58% of docket
4
Information Tech
4% of docket
0
Communications
0% of docket
7
Semiconductors
8% of docket
26
Mechanical / Eng
29% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

890 h
Manual time on pending OAs
178 h
Time saved (low, 20%)
312 h
Time saved (mid, 35%)
7.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHEN, YANXIN NMN 1 84.6% +26.4%
YANG, YI-SHAN 1 70.4% +53.0%
STANLEY, TYLER JAY 1 48.5% +51.5%
NUR, ABDULLAHI 1 88.2% +6.1%
ORKIN, ALEXANDER J 1 65.5% +26.8%
ZAKARIA, AKM 1 82.5% +16.2%
BOMAR, THOMAS S 1 83.0% +0.2%
HILSMIER, HEIDI ANN 1 53.8% +65.9%
PATEL, TULSIDAS C 1 42.9% +22.8%
ARIANI, KADE 1 75.0% +32.1%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19228322 HYPERSPECTRAL IMAGING FOR EARLY DETECTION OF ALZHEIMER'S DISEASE NUR, ABDULLAHI —

Hard Cases (54)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18109039 Cardiopulmonary Resuscitation Catheter and Related Systems and Methods GRAY, PHILLIP A 126d overdue
18501663 DEVICE FOR TREATMENT OF TRAUMATIC BRAIN INJURY AND RELATED SYSTEMS AND METHODS SIRCAR, ALISHA JITENDRA 98d overdue
18000258 COPOLYMERS FOR INTRACELLULAR THERAPEUTIC NUCLEIC ACID PAYLOAD DELIVERY SASTRI, SATYA B 66d overdue
18579604 MONITORING AND CLASSIFICATION OF CARDIAC ARREST RHYTHM DIETRICH, JOSEPH M 31d overdue
18337578 LOCAL VOLT/VAR CONTROLLERS WITH STABILITY GUARANTEES YOON, ERIC 5d overdue
18639608 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF MCDOWELL, BRIAN E 3d overdue
19041455 WIND-DRIVEN ENERGY APPARATUSES AND METHODS THEREOF PATEL, TULSIDAS C 2d overdue
17953981 NON-FIBRILLAR HEMOGLOBIN S OLIGOMERS AND METHODS TO IDENTIFY MODULATORS OF HEMOGLOBIN S POLYMERIZATION TURK, NEIL N 8d

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19041455 WIND-DRIVEN ENERGY APPARATUSES AND METHODS THEREOF PATEL, TULSIDAS C 2d overdue
19326385 ENGINEERED GENETIC INCOMPATIBILITY IN PLANTS SHEN, YANXIN NMN —
19153797 MULTIMODAL ULTRASOUND AND ACOUSTIC SYSTEM AND METHOD FOR NOVEL NON-INVASIVE HEARING ASSESSMENT AND INTRACRANIAL PRESSURE MONITORING YANG, YI-SHAN —
19236658 Multi-Speed Ergonomic Wheelchair And Devices And Methods Therefor STANLEY, TYLER JAY —
19184578 PULMONARY ARTERY FLOW RESTRICTOR ORKIN, ALEXANDER J —
19182191 MAGNETIC RESONANCE IMAGE RECONSTRUCTION WITH DEEP LEARNING-BASED OUTER VOLUME REMOVAL ZAKARIA, AKM —
19061008 ATRIAL FIBRILLATION INSTABILITY DIAGNOSIS AND TREATMENT HILSMIER, HEIDI ANN —
18961073 COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT ARIANI, KADE —

Top Art Units

Art UnitApps
3796 5
1632 4
3783 4
3774 3
1641 3
1796 3
1663 2
2877 2
3771 2
2896 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19326385 ENGINEERED GENETIC INCOMPATIBILITY IN PLANTS SHEN, YANXIN NMN 1663 §102§103§112 Non-Final OA — Pending Sep 11, 2025
19153797 MULTIMODAL ULTRASOUND AND ACOUSTIC SYSTEM AND METHOD FOR NOVEL NON-INVASIVE HEARING ASSESSMENT AND INTRACRANIAL PRESSURE MONITORING YANG, YI-SHAN 3798 §101§102§103§112 Non-Final OA — Pending Aug 05, 2025
19236658 Multi-Speed Ergonomic Wheelchair And Devices And Methods Therefor STANLEY, TYLER JAY 3611 §102§103§112 Non-Final OA — Pending Jun 12, 2025
19228322 HYPERSPECTRAL IMAGING FOR EARLY DETECTION OF ALZHEIMER'S DISEASE NUR, ABDULLAHI 2877 §103Other Non-Final OA — Pending Jun 04, 2025
19184578 PULMONARY ARTERY FLOW RESTRICTOR ORKIN, ALEXANDER J 3771 §103 Final Rejection — Pending Apr 21, 2025
19182191 MAGNETIC RESONANCE IMAGE RECONSTRUCTION WITH DEEP LEARNING-BASED OUTER VOLUME REMOVAL ZAKARIA, AKM 2858 §102§103 Non-Final OA — Pending Apr 17, 2025
19120136 BURROWING ROBOT AND BURROWING ROBOT HEAD BOMAR, THOMAS S 3674 §102§112Other Non-Final OA — Pending Apr 10, 2025
19061008 ATRIAL FIBRILLATION INSTABILITY DIAGNOSIS AND TREATMENT HILSMIER, HEIDI ANN 3796 §101 Non-Final OA — Pending Feb 24, 2025
19041455 WIND-DRIVEN ENERGY APPARATUSES AND METHODS THEREOF PATEL, TULSIDAS C 2896 §102§103 Non-Final OA 2d overdue Pending Jan 30, 2025
18961073 COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT ARIANI, KADE 1651 §103§112DP Non-Final OA — Pending Nov 26, 2024
18916866 SILICA-COATED STIMULUS-RESPONSIVE POLYMERIC NANOPARTICLES PATEL, RONAK C 1788 §103 Non-Final OA — Pending Oct 16, 2024
18915826 METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN MOLOYE, TITILAYO 1632 DP Non-Final OA — Pending Oct 15, 2024
18903394 MULTI-MODAL SYNCHRONIZATION THERAPY STICE, PAULA J 3796 §101§112DP Non-Final OA — Pending Oct 01, 2024
18846873 THERAPEUTIC COMPOUND AND SALTS ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §102§103§112 Non-Final OA — Pending Sep 13, 2024
18818917 MOTOR UNIT CHIP, MANUFACTURING METHOD THEREOF AND METHOD OF DETECTING PATHOLOGICAL EVENT USING THE SAME KELLY, ROBERT M 1638 §102§112 Non-Final OA — Pending Aug 29, 2024
18832026 ANTI-B7-H3 COMPOUNDS AND METHODS OF USE LIPPERT, JOHN WILLIAM 1615 §102§103 Non-Final OA — Pending Jul 22, 2024
18726717 HEMOSTATIC COMPOSITION CONTAINING RECOMBINANT HUMAN CLOTTING FACTORS, AND METHOD OF PRODUCING RAMIREZ, DELIA M 1652 §112 Non-Final OA — Pending Jul 03, 2024
18748562 ENCAPSULATED BIOFILM COMPOSITIONS AND METHODS ABDEL LATIF, MAHMOUD MOTAZ 1773 §103 Non-Final OA — Pending Jun 20, 2024
18669423 SYSTEM AND METHOD FOR DENOISING IN MAGNETIC RESONANCE IMAGING USING A TRANSFORM DOMAIN LOCAL LOW RANK TECHNIQUE CURRAN, GREGORY H 2852 §103 Non-Final OA — Pending May 20, 2024
18667481 SYSTEMS AND METHODS FOR TREATING STORMWATER WITH ANAMMOX BACTERIA VARMA, AKASH K 1773 §103§112 Non-Final OA — Pending May 17, 2024
18708411 COMPOSITIONS AND METHODS FOR TRANSCRIPTIONAL ACTIVATION STEPHENS, REBECCA JOHANNA 1663 §103§112DP Non-Final OA — Pending May 08, 2024
18654961 VIRAL ANTIGEN DISPLAY COMPOSITIONS AND METHODS CORNELIUS, CLAIRE ADRIENNE 1672 §103§112 Non-Final OA — Pending May 03, 2024
18649533 SYSTEMS AND METHODS FOR MODIFYING DAIRY PROTEIN FUNCTIONALITY BECKER, DREW E 1792 §102§103§112 Non-Final OA — Pending Apr 29, 2024
18705175 TOLL-LIKE RECEPTOR AGONISTS AND ANTAGONISTS AND USES THEREOF ONDACHI, PAULINE WANJIKU MUCH 1627 §103DP Non-Final OA — Pending Apr 26, 2024
18642224 PRECISION FUNCTIONAL MAPPING (PFM) TO PERSONALIZE NEUROMODULATION IN PSYCHIATRIC AND NEUROLOGICAL APPLICATIONS CHNG, JOY POH AI 3686 §101§112 Non-Final OA — Pending Apr 22, 2024
18639608 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF MCDOWELL, BRIAN E 1624 §102§103 Non-Final OA 3d overdue Pending Apr 18, 2024
18635934 ADAPTIVE REAL-TIME STATE SPACE CONTROL OF A NEUROSTIMULATION DEVICE LEE, BRYAN MCALLISTER 3796 §103 Non-Final OA 12d Pending Apr 15, 2024
18633908 THERAPEUTIC COMPOUNDS MILLER, DALE R 1693 §103 Non-Final OA — Pending Apr 12, 2024
18631916 METHODS AND COMPOSITIONS FOR IMPROVING IMMUNOTHERAPY LOGSDON, CHARLES 1662 §103§112 Non-Final OA — Pending Apr 10, 2024
18696252 PARALLEL TRANSMIT RADIO FREQUENCY PULSE DESIGN WITH DEEP LEARNING PATEL, RISHI R 2896 §103 Non-Final OA — Pending Mar 27, 2024
18696138 STENT AND METHOD FOR SECURING AIR FLOW BY RELIEVING STENOSIS OF RESPIRATORY ORGAN HU, ANN M 3774 §102§103 Non-Final OA — Pending Mar 27, 2024
18605241 METHODS OF FORMING AN OXIDE USING VAN DER WAALS MATERIALS TALBOT, BRIAN K 1784 §103§112 Non-Final OA — Pending Mar 14, 2024
18690594 SALMONELLA ENGINEERED FOR NONTOXIC COLONIZATION OF TUMORS STAVROU, CONSTANTINA E 1632 §102§103 Non-Final OA — Pending Mar 08, 2024
18593314 CONJUGATES AND METHODS OF USE THEREOF BOWERS, ERIN M 1653 §102§103 Non-Final OA — Pending Mar 01, 2024
18587203 SUSPENDED PARTICLE CONCENTRATION, DETECTION, AND ANALYSIS SCHNASE, PAUL DANIEL 2877 §103 Final Rejection 35d Pending Feb 26, 2024
18438184 BOTTLEBRUSH POLYMERS AND METHODS THEREOF KASSA, TIGABU 1619 §102§103 Non-Final OA — Pending Feb 09, 2024
18291525 BIOMATERIALS FOR EMBOLIZATION AND DRUG DELIVERY WORSHAM, JESSICA N 1615 §102§112 Non-Final OA — Pending Jan 23, 2024
18579604 MONITORING AND CLASSIFICATION OF CARDIAC ARREST RHYTHM DIETRICH, JOSEPH M 3796 §103§112 Final Rejection 31d overdue Pending Jan 16, 2024
18579222 SYSTEMS AND METHODS FOR CONTROLLING A MEDICAL DEVICE USING BAYESIAN PREFERENCE MODEL BASED OPTIMIZATION AND VALIDATION BAIG, RUMAISA RASHID 3796 §103§112 Non-Final OA — Pending Jan 12, 2024
18403891 HIGHLY FLUORINATED COMPOUNDS FOR 19F MRI-BASED THERMOMETRY BRAZIN, JACQUELINE 1798 §102§112 Non-Final OA — Pending Jan 04, 2024
18573327 COPOLYMERS AND DEGRADABLE PLASTICS INCLUDING SALICYLATES NGUYEN, HA S 1766 §102§103 Non-Final OA — Pending Dec 21, 2023
18570723 TARGETED ADAM17 BLOCKER COMPOUNDS, ANTI-ADAM17 ANTIBODIES, METHODS OF MAKING, AND METHODS OF USING HUYNH, PHUONG N 1641 §102§103§112 Non-Final OA — Pending Dec 15, 2023
18571000 APPARATUSES, SYSTEMS, AND METHODS FOR FASCIAL CLOSURE DORNBUSCH, DIANNE 3771 §103 Non-Final OA 9d Pending Dec 15, 2023
18540131 BEHAVIORAL FORENSICS IN SOCIAL NETWORKS MINCEY, JERMAINE A 2159 §101§103 Non-Final OA — Pending Dec 14, 2023
18536537 BIO-ENHANCED REMEDIATION AND OIL RECOVERY MODEL SYSTEM AND METHODS KASS, BENJAMIN JOSEPH 1796 §102§103§112 Non-Final OA — Pending Dec 12, 2023
18565831 METHODS OF USING ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T CELLS HAM, JIEUN 1643 §103§112DP Non-Final OA — Pending Nov 30, 2023
18565948 METHODS, DEVICES AND SYSTEMS FOR SEPARATING BIOLOGICAL ANALYTES FROM SAMPLES FISHER, BRITTANY I 1796 §102§103§112 Non-Final OA — Pending Nov 30, 2023
18501663 DEVICE FOR TREATMENT OF TRAUMATIC BRAIN INJURY AND RELATED SYSTEMS AND METHODS SIRCAR, ALISHA JITENDRA 3792 §102§103§112 Final Rejection 98d overdue Pending Nov 03, 2023
18558837 DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK) ASSEMBLIES AND INJECTORS WITH FRICTION-REDUCING COATINGS SHARMA, YASHITA 3774 §102§103 Non-Final OA — Pending Nov 03, 2023
18286955 Glycan Targets of Serum IgG and IgM Antibodies WEN, SHARON X 1641 §103 Non-Final OA — Pending Oct 13, 2023

View all 89 →

Managing Regents of the University of Minnesota's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Regents of the University of Minnesota have?

Regents of the University of Minnesota has 89 pending office actions as of October 2026, spread across 59 art units and 89 examiners.

Which USPTO examiner handles the most Regents of the University of Minnesota applications?

Yanxin Nmn Shen has the most, with 1 of Regents of the University of Minnesota's pending office actions.

What technology area are Regents of the University of Minnesota's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month